文献速递糖尿病

早期儿童体重指数与COVID-19大流行、防控措施及胰岛自身免疫在1型糖尿病风险增高儿童中的关联

Early-childhood body mass index and its association with the COVID-19 pandemic, containment measures and islet autoimmunity in children with increased risk for type 1 diabetes.
PubMed 文献 · Diabetologia · 2024-01-12

研究纳入1050名1型糖尿病遗传风险增高的儿童,随访2018年2月至2023年5月。COVID-19大流行与儿童BMI时间变化值升高(β=0.39)及9月龄超重风险升高(β=0.44)相关;大流行期间限制严格度指数越高,BMI和超重风险越高。校正大流行后,9月龄年龄校正BMI较高(HR 1.16)和超重风险较高(HR 1.68)与至5.5岁发生胰岛自身免疫风险增加相关。

要点

  • COVID-19大流行与儿童BMI时间变化值升高(β=0.39)及9月龄超重风险升高(β=0.44)相关。
  • 大流行期间限制严格度指数每增加10单位,BMI时间变化值β=0.02、9月龄BMI β=0.13、9月龄超重风险β=0.23。
  • 9月龄年龄校正BMI较高(HR 1.16)和超重风险较高(HR 1.68)与至5.5岁胰岛自身免疫风险增加相关。

核心结论

  • 早期儿童BMI在COVID-19大流行期间升高,并受大流行限制水平影响。
  • 校正COVID-19大流行后,遗传易感1型糖尿病儿童早期BMI升高与儿童期胰岛自身免疫风险增加相关。

研究设计与样本

  • 研究纳入1050名参加Primary Oral Insulin Trial的儿童,年龄从4.0月龄至5.5岁。
  • 数据收集时间为2018年2月至2023年5月。
  • COVID-19大流行开始定义为2020年3月18日,并使用严格度指数评估防控措施严格程度。
  • 胰岛自身免疫定义为出现持续确认的多个胰岛自身抗体,或出现一个及以上胰岛自身抗体并发生1型糖尿病。
  • 采用多变量线性混合效应模型、线性回归和逻辑回归评估大流行及严格度指数对早期儿童BMI的影响,采用Cox比例风险模型评估BMI对胰岛自身免疫风险的影响。

主要发现

  • COVID-19大流行与BMI时间变化值升高相关(β=0.39;95% CI 0.30,0.47)。
  • COVID-19大流行与9月龄超重风险升高相关(β=0.44;95% CI 0.03,0.84)。
  • 大流行期间严格度指数每增加10单位,与BMI时间变化值正相关(β=0.02;95% CI 0.00,0.04)。
  • 大流行期间严格度指数每增加10单位,与9月龄BMI正相关(β=0.13;95% CI 0.01,0.25),与9月龄超重风险正相关(β=0.23;95% CI 0.03,0.43)。
  • 9月龄年龄校正BMI较高与至5.5岁发生胰岛自身免疫风险增加相关(HR 1.16;95% CI 1.01,1.32)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: The aim of this study was to determine whether BMI in early childhood was affected by the COVID-19 pandemic and containment measures, and whether it was associated with the risk for islet autoimmunity. METHODS: Between February 2018 and May 2023, data on BMI and islet autoimmunity were collected from 1050 children enrolled in the Primary Oral Insulin Trial, aged from 4.0 months to 5.5 years of age. The start of the COVID-19 pandemic was defined as 18 March 2020, and a stringency index was used to assess the stringency of containment measures. Islet autoimmunity was defined as either the development of persistent confirmed multiple islet autoantibodies, or the development of one or more islet autoantibodies and type 1 diabetes. Multivariate linear mixed-effect, linear and logistic regression methods were applied to assess the effect of the COVID-19 pandemic and the stringency index on early-childhood BMI measurements (BMI as a time-varying variable, BMI at 9 months of age and overweight risk at 9 months of age), and Cox proportional hazard models were used to assess the effect of BMI measurements on islet autoimmunity risk. RESULTS: The COVID-19 pandemic was associated with increased time-varying BMI (β = 0.39; 95% CI 0.30, 0.47) and overweight risk at 9 months (β = 0.44; 95% CI 0.03, 0.84). During the COVID-19 pandemic, a higher stringency index was positively associated with time-varying BMI (β = 0.02; 95% CI 0.00, 0.04 per 10 units increase), BMI at 9 months (β = 0.13; 95% CI 0.01, 0.25) and overweight risk at 9 months (β = 0.23; 95% CI 0.03, 0.43). A higher age-corrected BMI and overweight risk at 9 months were associated with increased risk for developing islet autoimmunity up to 5.5 years of age (HR 1.16; 95% CI 1.01, 1.32 and HR 1.68, 95% CI 1.00, 2.82, respectively). CONCLUSIONS/INTERPRETATION: Early-childhood BMI increased during the COVID-19 pandemic, and was influenced by the level of restrictions during the pandemic. Controlling for the COVID-19 pandemic, elevated BMI during early childhood was associated with increased risk for childhood islet autoimmunity in children with genetic susceptibility to type 1 diabetes.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Hummel S, Rosenberger S, von dem Berge T, et al. Early-childhood body mass index and its association with the COVID-19 pandemic, containment measures and islet autoimmunity in children with increased risk for type 1 diabetes. Diabetologia. 2024. PMID: 38214711. doi:10.1007/s00125-023-06079-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。